Post-IPO Equity - Spero Therapeutics
Investment Firm
Overview
Spero Therapeutics develops therapeutics for treatment of gram-negative infections.
Announced Date
Sep 22, 2022
Funding Type
Post Ipo Equity
Highlights
Location
United States, North America
Social
Investor Lead
Participant Investors
1
| Investor Name |
|---|
Round Details and Background
Spero Therapeutics raised $9000000 on 2022-09-22 in Post-IPO Equity
Spero Therapeutics develops therapeutics for treatment of gram-negative infections.
Company Funding History
15
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| Mar 08, 2017 |  Series C - Spero Therapeutics | 9 | - | 51.7M |
| Feb 02, 2016 | Series B - Spero Therapeutics | 8 | - | 30.0M |
| Jun 08, 2015 | Series A - Spero Therapeutics | 8 | - | 30.0M |
| Apr 09, 2014 | Series A - Spero Therapeutics | 4 | - | 3.0M |
Recent Activity
There is no recent news or activity for this profile.